Clinical Trial Update: To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema [Phase 1]

View source ↗

Summary

Phase 1 trial comparing intravitreal bevacizumab and triamcinolone for resistant uveitic cystoid macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitic Cystoid Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Resistant Cystoid Macular Edema | Phase 1 | Status: UNKNOWN